In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo chat with Cathleen McCabe, MD, about the ASCRS Foundation and role models in ophthalmology; plus, the latest news in eye care.

• Welcome to the Eyeluminaries podcast :05 • Review of episode 25 :46 • Bausch + Lomb acquires Trukera Medical 1:32 • CMS proposes cutting physician payments for fifth straight year 4:09 • FDA clears Alcon's Unity cataract system, Unity vitreoretinal cataract system 7:40 • FDA approves Eylea biosimilar FYB203/Ahzantive 11:07 • Intro of Cathleen McCabe, MD 13:07 • American Society of Cataract and Refractive Surgery (ASCRS) has become an important organization to advocate, educate and organize doctors and their practices. As future president of the organization, what vision do you have for the organization? 15:26 • In reference to your practice, what challenges are you facing and how do you overcome them? 18:59 • Besides the two of us, who do you admire in ophthalmology? 23:37 • Tell us about your work, what you do and how you do it. 27:21 • Preview of episode 27 33:30 • Thanks 34:58

John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.

Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA.

Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL.

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian.

Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. McCabe reports no relevant financial disclosures.